Gerardo Ferrer

11PUBLICATIONS
68CO-AUTHORS
Haematological tumoursGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 27, 2025
Age-Driven Genetic and Epigenetic Heterogeneity in B-ALL.

Yoana Veselinova, Manel Esteller, Gerardo Ferrer

|Feb 01, 2024
Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy.

Ignacio Campillo-Marcos, Marta Casado-Pelaez, Veronica Davalos

|Apr 18, 2023
Duvelisib Eliminates CLL B Cells, Impairs CLL-Supporting Cells, and Overcomes Ibrutinib Resistance in a Xenograft Model.

Shih-Shih Chen, Jacqueline C Barrientos, Gerardo Ferrer

|Apr 19, 2022
Biological and Molecular Factors Predicting Response to Adoptive Cell Therapies in Cancer.

Gerardo Ferrer, Damiana Álvarez-Errico, Manel Esteller

|Sep 28, 2021
Epigenetic Profiling and Response to CD19 Chimeric Antigen Receptor T-Cell Therapy in B-Cell Malignancies.

Carlos A Garcia-Prieto, Lorea Villanueva, Alberto Bueno-Costa

|May 03, 2021
Myeloid-derived suppressor cell subtypes differentially influence T-cell function, T-helper subset differentiation, and clinical course in CLL.

Gerardo Ferrer, Byeongho Jung, Pui Yan Chiu

Pageof 2

Frequent Collaborators

7 joint publications

Manel Esteller

4 joint publications

Nicholas Chiorazzi

3 joint publications

Steven L Allen

3 joint publications

Carlos A Garcia-Prieto